XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects

Giuseppe Matullo, Domenico Palli, Marco Peluso, Simonetta Guarrera, Sonia Carturan, Egidio Celentano, Vittorio Krogh, Armelle Munnia, Rosario Tumino, Silvia Polidoro, Alberto Piazza, Paolo Vineis

Research output: Contribution to journalArticle

436 Citations (Scopus)

Abstract

DNA repair genes have an important role in protecting individuals from cancer-causing agents. Polymorphisms in several DNA repair genes have been identified and individuals with non-dramatic reductions in the capacity to repair DNA damage are observed in the population, but the impact of specific genetic variants on repair phenotype and cancer risk has not yet been clarified. In 308 healthy Italian individuals belonging to the prospective European project EPIC, we have investigated the relationship between DNA damage, as measured by 32P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative adduct level (RAL) per 109 normal nucleotides by DNA 32P-post-labelling assay in white blood cells from peripheral blood. Genotyping was performed by PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated with higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were associated with higher DNA adduct levels only in never-smokers. XRCC3-241Met homozygotes had an average DNA adduct level of 11.44 ± 1.48 (±SE) compared with 7.69 ± 0.88 in Thr/Met heterozygotes and 6.94 ± 1.11 in Thr/Thr homozygotes (F = 3.206, P = 0.042). Never-smoking XRCC1-399Gln homozygotes had an average DNA adduct level of 15.60 ± 5.42 compared with 6.16 ± 0.97 in Gln/Arg heterozygotes and 6.78 ± 1.10 in Arg/Arg homozygotes (F = 5.237, P = 0.007). A significant odds ratio (3.81, 95% CI 1.02-14.16) to have DNA adduct levels above median value was observed for XPD-751Gln versus XPD-751Lys never-smoking homozygotes after adjustment for several confounders. These data show that all the analysed polymorphisms could result in deficient DNA repair and suggest a need for further investigation into the possible interactions between these polymorphisms, smoking and other risk factors.

Original languageEnglish
Pages (from-to)1437-1445
Number of pages9
JournalCarcinogenesis
Volume22
Issue number9
Publication statusPublished - 2001

Fingerprint

DNA Adducts
Healthy Volunteers
Homozygote
Smoking
Genes
Exons
Heterozygote
DNA Repair
DNA Damage
DNA Repair-Deficiency Disorders
Genetic Polymorphisms
Restriction Fragment Length Polymorphisms
Neoplasms
Leukocytes
Nucleotides
Odds Ratio
Phenotype
Polymerase Chain Reaction
DNA
Population

ASJC Scopus subject areas

  • Cancer Research

Cite this

Matullo, G., Palli, D., Peluso, M., Guarrera, S., Carturan, S., Celentano, E., ... Vineis, P. (2001). XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis, 22(9), 1437-1445.

XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. / Matullo, Giuseppe; Palli, Domenico; Peluso, Marco; Guarrera, Simonetta; Carturan, Sonia; Celentano, Egidio; Krogh, Vittorio; Munnia, Armelle; Tumino, Rosario; Polidoro, Silvia; Piazza, Alberto; Vineis, Paolo.

In: Carcinogenesis, Vol. 22, No. 9, 2001, p. 1437-1445.

Research output: Contribution to journalArticle

Matullo, G, Palli, D, Peluso, M, Guarrera, S, Carturan, S, Celentano, E, Krogh, V, Munnia, A, Tumino, R, Polidoro, S, Piazza, A & Vineis, P 2001, 'XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects', Carcinogenesis, vol. 22, no. 9, pp. 1437-1445.
Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22(9):1437-1445.
Matullo, Giuseppe ; Palli, Domenico ; Peluso, Marco ; Guarrera, Simonetta ; Carturan, Sonia ; Celentano, Egidio ; Krogh, Vittorio ; Munnia, Armelle ; Tumino, Rosario ; Polidoro, Silvia ; Piazza, Alberto ; Vineis, Paolo. / XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. In: Carcinogenesis. 2001 ; Vol. 22, No. 9. pp. 1437-1445.
@article{5fd3e64b19bd45b3aa7fe8418825ef6b,
title = "XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects",
abstract = "DNA repair genes have an important role in protecting individuals from cancer-causing agents. Polymorphisms in several DNA repair genes have been identified and individuals with non-dramatic reductions in the capacity to repair DNA damage are observed in the population, but the impact of specific genetic variants on repair phenotype and cancer risk has not yet been clarified. In 308 healthy Italian individuals belonging to the prospective European project EPIC, we have investigated the relationship between DNA damage, as measured by 32P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative adduct level (RAL) per 109 normal nucleotides by DNA 32P-post-labelling assay in white blood cells from peripheral blood. Genotyping was performed by PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated with higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were associated with higher DNA adduct levels only in never-smokers. XRCC3-241Met homozygotes had an average DNA adduct level of 11.44 ± 1.48 (±SE) compared with 7.69 ± 0.88 in Thr/Met heterozygotes and 6.94 ± 1.11 in Thr/Thr homozygotes (F = 3.206, P = 0.042). Never-smoking XRCC1-399Gln homozygotes had an average DNA adduct level of 15.60 ± 5.42 compared with 6.16 ± 0.97 in Gln/Arg heterozygotes and 6.78 ± 1.10 in Arg/Arg homozygotes (F = 5.237, P = 0.007). A significant odds ratio (3.81, 95{\%} CI 1.02-14.16) to have DNA adduct levels above median value was observed for XPD-751Gln versus XPD-751Lys never-smoking homozygotes after adjustment for several confounders. These data show that all the analysed polymorphisms could result in deficient DNA repair and suggest a need for further investigation into the possible interactions between these polymorphisms, smoking and other risk factors.",
author = "Giuseppe Matullo and Domenico Palli and Marco Peluso and Simonetta Guarrera and Sonia Carturan and Egidio Celentano and Vittorio Krogh and Armelle Munnia and Rosario Tumino and Silvia Polidoro and Alberto Piazza and Paolo Vineis",
year = "2001",
language = "English",
volume = "22",
pages = "1437--1445",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects

AU - Matullo, Giuseppe

AU - Palli, Domenico

AU - Peluso, Marco

AU - Guarrera, Simonetta

AU - Carturan, Sonia

AU - Celentano, Egidio

AU - Krogh, Vittorio

AU - Munnia, Armelle

AU - Tumino, Rosario

AU - Polidoro, Silvia

AU - Piazza, Alberto

AU - Vineis, Paolo

PY - 2001

Y1 - 2001

N2 - DNA repair genes have an important role in protecting individuals from cancer-causing agents. Polymorphisms in several DNA repair genes have been identified and individuals with non-dramatic reductions in the capacity to repair DNA damage are observed in the population, but the impact of specific genetic variants on repair phenotype and cancer risk has not yet been clarified. In 308 healthy Italian individuals belonging to the prospective European project EPIC, we have investigated the relationship between DNA damage, as measured by 32P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative adduct level (RAL) per 109 normal nucleotides by DNA 32P-post-labelling assay in white blood cells from peripheral blood. Genotyping was performed by PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated with higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were associated with higher DNA adduct levels only in never-smokers. XRCC3-241Met homozygotes had an average DNA adduct level of 11.44 ± 1.48 (±SE) compared with 7.69 ± 0.88 in Thr/Met heterozygotes and 6.94 ± 1.11 in Thr/Thr homozygotes (F = 3.206, P = 0.042). Never-smoking XRCC1-399Gln homozygotes had an average DNA adduct level of 15.60 ± 5.42 compared with 6.16 ± 0.97 in Gln/Arg heterozygotes and 6.78 ± 1.10 in Arg/Arg homozygotes (F = 5.237, P = 0.007). A significant odds ratio (3.81, 95% CI 1.02-14.16) to have DNA adduct levels above median value was observed for XPD-751Gln versus XPD-751Lys never-smoking homozygotes after adjustment for several confounders. These data show that all the analysed polymorphisms could result in deficient DNA repair and suggest a need for further investigation into the possible interactions between these polymorphisms, smoking and other risk factors.

AB - DNA repair genes have an important role in protecting individuals from cancer-causing agents. Polymorphisms in several DNA repair genes have been identified and individuals with non-dramatic reductions in the capacity to repair DNA damage are observed in the population, but the impact of specific genetic variants on repair phenotype and cancer risk has not yet been clarified. In 308 healthy Italian individuals belonging to the prospective European project EPIC, we have investigated the relationship between DNA damage, as measured by 32P-DNA adduct levels, and three genetic polymorphisms in different repair genes: XRCC1-Arg399Gln (exon 10), XRCC3-Thr241Met (exon 7) and XPD-Lys751Gln (exon 23). DNA adduct levels were measured as relative adduct level (RAL) per 109 normal nucleotides by DNA 32P-post-labelling assay in white blood cells from peripheral blood. Genotyping was performed by PCR-RFLP analysis. The XRCC3-241Met variant was significantly associated with higher DNA adduct levels, whereas XRCC1-399Gln and XPD-751Gln were associated with higher DNA adduct levels only in never-smokers. XRCC3-241Met homozygotes had an average DNA adduct level of 11.44 ± 1.48 (±SE) compared with 7.69 ± 0.88 in Thr/Met heterozygotes and 6.94 ± 1.11 in Thr/Thr homozygotes (F = 3.206, P = 0.042). Never-smoking XRCC1-399Gln homozygotes had an average DNA adduct level of 15.60 ± 5.42 compared with 6.16 ± 0.97 in Gln/Arg heterozygotes and 6.78 ± 1.10 in Arg/Arg homozygotes (F = 5.237, P = 0.007). A significant odds ratio (3.81, 95% CI 1.02-14.16) to have DNA adduct levels above median value was observed for XPD-751Gln versus XPD-751Lys never-smoking homozygotes after adjustment for several confounders. These data show that all the analysed polymorphisms could result in deficient DNA repair and suggest a need for further investigation into the possible interactions between these polymorphisms, smoking and other risk factors.

UR - http://www.scopus.com/inward/record.url?scp=0034812088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034812088&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 1437

EP - 1445

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -